UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Immunotherapies Opdivo, Keytruda score high in real setting
Immunotherapies Opdivo Inj. and Keytruda Inj. showed excellent efficacy and...
by Kim Eun-young
|
2019-09-10 12:49
라인
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’
Bayer said that it has presented two real-world research results that have ...
by Lee Han-soo
|
2019-09-09 16:54
라인
Hanmi to unveil investigator-led P2 progress for cancer treatment
Hanmi said that MD Anderson Cancer Center has presented the development of ...
by Lee Han-soo
|
2019-09-09 15:47
라인
Novo Nordisk's Ryzodeg leads Korean mixed insulin market
Novo Nordisk Korea said Monday that Ryzodeg, the company's soluble insu...
by Lee Han-soo
|
2019-09-09 14:18
라인
PARP inhibitors to show intense rivalry at ESMO 2019
The highlight of the upcoming ESMO 2019, a cancer meeting in Europe, will b...
by Kim Yun-mi
|
2019-09-09 11:56
라인
Ildong to sell GSK’s influenza treatment
Ildong Pharmaceutical said that it would exclusively promote and market GSK...
by Lee Han-soo
|
2019-09-06 17:02
라인
Yuhan to expand biz scope to central nervous system disease
“We will broaden open innovation toward the academic sector and expand our ...
by Jeong Sae-im
|
2019-09-06 14:56
라인
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan
Seoul Pharmaceutical said that it would export $4.9 million worth of its or...
by Lee Han-soo
|
2019-09-05 17:04
라인
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon
|
2019-09-05 16:24
라인
Daewoong, Medytox squabble over appraisal of additional spore for Nabota
Daewoong Pharmaceutical said that a recent test by the U.S. International T...
by Lee Han-soo
|
2019-09-05 14:35
라인
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union
Takeda Korea, which took over Shire Korea in January according to their hea...
by Lee Han-soo
|
2019-09-04 17:06
라인
JW Pharmaceutical acquires Vietnamese drugmaker
JW Pharmaceutical said that it has taken over Euvipharm, a Vietnamese pharm...
by Lee Han-soo
|
2019-09-04 15:16
라인
Takeda Korea vows to release 16 new drugs by 2023
Takeda Pharmaceutical Korea on Tuesday held the first news conference after...
by Kim Yun-mi
|
2019-09-03 15:40
라인
SK goes global by developing new drugs, conducting CDMO biz
SK Holdings is integrating three pharmaceutical production subsidiaries aro...
by Jeong Sae-im
|
2019-09-03 14:58
라인
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific
Hanmi Pharmaceutical and Daewoong Pharmaceutical were included in the top 2...
by Jeong Sae-im
|
2019-09-02 17:33
라인
Antidiabetic Forxiga proves efficacy in heart failure
AstraZeneca said it has confirmed that its diabetes drug Forxiga (ingredien...
by Kim Yun-mi
|
2019-09-02 11:35
라인
Daewoong, Medytox differ in interpreting spore appraisal for Nabota
Daewoong Pharmaceutical said Friday that it has gained the upper hand in th...
by Lee Han-soo
|
2019-08-30 16:26
라인
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi
|
2019-08-30 16:26
라인
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
The boycott of Japanese products has been intensifying over the past few mo...
by Lee Han-soo
|
2019-08-30 15:58
라인
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im
|
2019-08-30 14:49
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top